ESMO 2019 | Updates on HPV+ oropharyngeal cancer – de-escalation and reducing costs with cisplatin

Hisham Mehanna

Hisham Mehanna, PhD, BMedSc, MBChB, FRCS, FRCS(ORL-HNS), University of Birmingham, Birmingham, UK, talks about treatment de-escalation (NCT01874171) and also reducing treatment cost with cisplatin for HPV+ oropharyngeal cancer. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video